Ironwood Pharmaceuticals Inc Net Income per Employee (IRWD), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Ironwood Pharmaceuticals inc   (NASDAQ: IRWD)
 

Ironwood Pharmaceuticals Inc Net Income per Employee

IRWD's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 49.3% in the third quarter 2026, year on year to cumulative value of $150 million, and with 100 employees, Ironwood Pharmaceuticals Inc 's income per employee grew on trailing twelve month basis to $ 1,496,260. The income per employee at Ironwood Pharmaceuticals Inc ' was above the company average.
The Healthcare sector has seen employees of 22 other companies achieving higher income per employee. While income per employee remained unchanged compared to the previous quarter at no. 201.


What is Income per Employee Ratio?






IRWD Net Income per Employee (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Net Income Change 49.3 % 117.34 % - - 999.29 %
Net Income per Employee (TTM) $ 1,496,260 1,298,680 1,021,760 240,170 285,490
IRWD's Total Ranking # 201 # 201 # 1005 # 1074 #
Seq. Net Income Change 16.66 % 25.8 % - - 69.84 %


IRWD Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 23
Healthcare Sector # 29
Overall Market # 201

Net Income per Employee Statistics
High Average Low
$ 5,302,780 $ -906,371 $ -10,814,350
(Sep 30 2021)   (Mar 31 2024)







Companies with similar Income per Employee for 12 month ending Sep 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2026Number of Employees Sep 30 2026
Aurinia Pharmaceuticals Inc   2,455,203.13 $ 314.266  Million 128 
Rallybio Corporation  1,915,000.00 $ 26.810  Million 14 
Exelixis Inc   1,454,396.69 $ 1,668.193  Million 1,147 
Zevra Therapeutics Inc   1,273,049.18 $ 77.656  Million 61 
Ligand Pharmaceuticals Incorporated  1,094,936.17 $ 51.462  Million 47 
Alnylam Pharmaceuticals Inc   1,089,695.60 $ 2,724.239  Million 2,500 
Nurix Therapeutics Inc   930,211.36 $ 294.877  Million 317 
Krystal Biotech Inc   763,281.36 $ 225.168  Million 295 


Date modified: 2026-11-08T13:41:32+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.